Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

DANA-FARBER CANCER INSTITUTE, INC.

NPI: 1346433257 · BOSTON, MA 02115 · Medical Oncology Physician · NPI assigned 08/23/2007

$4.81M
Total Medicaid Paid
32,496
Total Claims
20,874
Beneficiaries
74
Codes Billed
2018-03
First Month
2024-09
Last Month

Provider Details

Authorized OfficialDEMBINSKI, PAUL (SENIOR DIRECTOR OF PFS)
Parent OrganizationDANA-FARBER CANCER INSTITUTE, INC.
NPI Enumeration Date08/23/2007

Related Entities

Other providers sharing the same authorized official: DEMBINSKI, PAUL

ProviderCityStateTotal Paid
DANA-FARBER CANCER INSTITUTE, INC. BOSTON MA $240.21M
DANA-FARBER CANCER INSTITUTE, INC. BOSTON MA $24K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 13,607 $2.15M
2019 16,565 $2.55M
2020 68 $2K
2021 416 $7K
2022 46 $2K
2023 1,382 $79K
2024 412 $21K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
80053 Comprehensive metabolic panel 2,633 1,704 $710K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1,788 905 $677K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2,027 1,454 $414K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,336 1,160 $349K
96375 Therapeutic injection; each additional sequential IV push 1,133 620 $343K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1,059 912 $255K
74177 Computed tomography, abdomen and pelvis; with contrast material 122 122 $217K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3,073 2,072 $184K
71260 Computed tomography, thorax, diagnostic; with contrast material 221 221 $153K
96411 612 416 $151K
80050 General health panel 368 312 $144K
99215 Prolong outpt/office vis 448 402 $134K
96417 472 293 $118K
96409 440 276 $96K
96361 Intravenous infusion, hydration; each additional hour 258 140 $82K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 278 275 $55K
99233 Prolong inpt eval add15 m 1,290 385 $55K
83735 2,042 1,197 $55K
86850 530 323 $49K
96367 309 219 $44K
96415 117 62 $42K
99232 Subsequent hospital care, per day, moderate complexity 903 216 $39K
J2469 Injection, palonosetron hcl, 25 mcg 176 114 $38K
77067 Screening mammography, bilateral, including computer-aided detection 193 193 $32K
86900 570 345 $30K
99205 Prolong outpt/office vis 80 73 $28K
84100 1,487 875 $28K
86901 522 317 $27K
82378 329 239 $25K
85027 823 487 $24K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 76 58 $21K
J0185 Injection, aprepitant, 1 mg 38 26 $21K
82248 1,220 749 $20K
83615 707 532 $17K
82784 157 138 $16K
80048 Basic metabolic panel (calcium, ionized) 111 63 $14K
99223 Prolong inpt eval add15 m 104 100 $14K
J1453 Injection, fosaprepitant, 1 mg 19 12 $12K
85007 786 456 $12K
J9370 Vincristine sulfate, 1 mg 458 300 $9K
80076 48 36 $6K
99222 Initial hospital care, per day, moderate complexity 66 66 $6K
84439 130 105 $6K
82565 251 193 $5K
82247 341 195 $4K
90686 111 111 $4K
84450 238 152 $3K
G0008 Administration of influenza virus vaccine 107 107 $2K
80051 29 21 $2K
J8540 Dexamethasone, oral, 0.25 mg 457 239 $2K
81001 109 70 $2K
99238 Hospital discharge day management, 30 minutes or less 32 30 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg 485 277 $1K
A9585 Injection, gadobutrol, 0.1 ml 14 13 $1K
82310 50 34 $1K
84520 58 39 $1K
J3489 Injection, zoledronic acid, 1 mg 13 12 $1K
83516 29 20 $1K
81003 58 39 $1K
84702 16 14 $931.68
99231 Subsequent hospital care, per day, straightforward or low complexity 30 17 $682.24
82947 26 17 $677.15
J3490 Unclassified drugs 23 12 $667.92
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 15 12 $647.76
J3475 Injection, magnesium sulfate, per 500 mg 28 12 $639.55
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 121 69 $549.51
85045 32 29 $493.00
84132 24 16 $488.75
82374 23 15 $397.91
84295 19 12 $363.47
84550 16 12 $299.20
J1200 Injection, diphenhydramine hcl, up to 50 mg 99 65 $173.92
J9250 Methotrexate sodium, 5 mg 43 24 $134.49
J1100 Injection, dexamethasone sodium phosphate, 1 mg 40 26 $60.73